Billions of T-Cells Clear Woman’s Breast Cancer in Study – Bloomberg
Bloomberg |
Billions of T–Cells Clear Woman's Breast Cancer in Study
Bloomberg The immunotherapy field has seen major breakthroughs in the past year, including the approval of two so-called CAR-T treatments from Gilead and Novartis AG that extract T–cells from a patient's blood and re-engineer them to recognize malignancies. New Immunotherapy Treatment Removes All Tumors In Woman With Advanced Metastatic Breast Cancer In a first, scientists use immunotherapy to rid patient of advanced breast cancer |
